These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23258792)

  • 1. Cellular microparticles in the pathogenesis of pulmonary hypertension.
    Amabile N; Guignabert C; Montani D; Yeghiazarians Y; Boulanger CM; Humbert M
    Eur Respir J; 2013 Jul; 42(1):272-9. PubMed ID: 23258792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles, vascular function and hypertension.
    Boulanger CM
    Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of procoagulant microparticles improves haemodynamic dysfunction during septic shock in rats.
    Boisramé-Helms J; Delabranche X; Degirmenci SE; Zobairi F; Berger A; Meyer G; Burban M; Mostefai HA; Levy B; Toti F; Meziani F
    Thromb Haemost; 2014 Jan; 111(1):154-64. PubMed ID: 24108660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients.
    Amabile N; Heiss C; Chang V; Angeli FS; Damon L; Rame EJ; McGlothlin D; Grossman W; De Marco T; Yeghiazarians Y
    J Heart Lung Transplant; 2009 Oct; 28(10):1081-6. PubMed ID: 19782291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.
    Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The many faces of endothelial microparticles.
    Dignat-George F; Boulanger CM
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial microparticles: missing link in endothelial dysfunction?
    Yong PJ; Koh CH; Shim WS
    Eur J Prev Cardiol; 2013 Jun; 20(3):496-512. PubMed ID: 22496273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles in cardiovascular disease pathophysiology and outcomes.
    Viera AJ; Mooberry M; Key NS
    J Am Soc Hypertens; 2012; 6(4):243-52. PubMed ID: 22789878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endothelial progenitor cells, microparticles and vascular disease.
    Mehta JL; Szwedo J
    J Hypertens; 2010 Aug; 28(8):1611-3. PubMed ID: 20647855
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial microparticles as conveyors of information in atherosclerotic disease.
    Schiro A; Wilkinson FL; Weston R; Smyth JV; Serracino-Inglott F; Alexander MY
    Atherosclerosis; 2014 Jun; 234(2):295-302. PubMed ID: 24721189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive oxygen species as therapeutic targets in pulmonary hypertension.
    Freund-Michel V; Guibert C; Dubois M; Courtois A; Marthan R; Savineau JP; Muller B
    Ther Adv Respir Dis; 2013 Jun; 7(3):175-200. PubMed ID: 23328248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell-derived microparticules: key players at the crossroad between inflammation and thrombosis].
    Sabatier F; Lacroix R; Leroyer AS; Cointe S; Dignat-George F
    Transfus Clin Biol; 2011 Apr; 18(2):62-9. PubMed ID: 21444231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte-derived microparticles in vascular homeostasis.
    Angelillo-Scherrer A
    Circ Res; 2012 Jan; 110(2):356-69. PubMed ID: 22267840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles: biomarkers and beyond.
    Burger D; Schock S; Thompson CS; Montezano AC; Hakim AM; Touyz RM
    Clin Sci (Lond); 2013 Apr; 124(7):423-41. PubMed ID: 23249271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis.
    Leroyer AS; Anfosso F; Lacroix R; Sabatier F; Simoncini S; Njock SM; Jourde N; Brunet P; Camoin-Jau L; Sampol J; Dignat-George F
    Thromb Haemost; 2010 Sep; 104(3):456-63. PubMed ID: 20664896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages.
    López M; San Román J; Estrada V; Vispo E; Blanco F; Soriano V
    AIDS Rev; 2012; 14(4):223-30. PubMed ID: 23258297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles and cardiovascular diseases.
    Voukalis C; Shantsila E; Lip GYH
    Ann Med; 2019; 51(3-4):193-223. PubMed ID: 31007084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.